Search   
MSDS 
:
 Lead(II) Iodide, 99%
CAS 
:
 10101-63-0
SYNONYMS 
:
 
**** SECTION 2 - COMPOSITION, INFORMATION ON INGREDIENTS ****

+----------------+--------------------------------------+----------+-----------+
| CAS# | Chemical Name | % | EINECS# |
|----------------|--------------------------------------|----------|-----------|
| 10101-63-0 |Lead (II) Iodide | 99 | 233-256-9 |
+----------------+--------------------------------------+----------+-----------+
Hazard Symbols: T N
Risk Phrases: 20/22 33 61 62 50/53

**** SECTION 3 - HAZARDS IDENTIFICATION ****

EMERGENCY OVERVIEW
Harmful by inhalation and if swallowed. Danger of cumulative
effects. May cause harm to the unborn child. Possible risk of
impaired fertility. Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.

Potential Health Effects
Eye:
May cause eye irritation. Causes eye irritation and possible
injury.
Skin:
May cause skin irritation. Causes skin irritation.
Ingestion:
Harmful if swallowed. Causes gastrointestinal irritation with
nausea, vomiting and diarrhea. May cause liver and kidney damage.
May cause cardiac disturbances. Exposure may cause anemia and other
blood abnormalities. Ingestion of lead compounds can produce
symptoms of lead poisoning. Symptoms of lead poisoning or plumbism
include weakness, weight loss, lassitude, insomnia, and hypotension.
It also includes constipation, anorexia, abdominal discomfort and
colic. Acute lead poisoning can cause muscle weakness, "lead line" on
the gums, metallic taste, definite loss of appetite, insomnia,
dizziness, high lead levels in blood and urine with shock, coma and
death in extreme cases.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation. Inhalation
of fumes may cause metal fume fever, which is characterized by
flu-like symptoms with metallic taste, fever, chills, cough,
weakness, chest pain, muscle pain and increased white blood cell
count. May cause effects similar to those described for ingestion.
May cause anemia. May cause cardiac abnormalities.
Chronic:
May cause liver and kidney damage. May cause cancer in humans.
Chronic exposure to lead may result in plumbism which is
characterized by lead line in gum, headache, muscle weakness, mental
changes. Chronic expsoure to lead may cause adverse effects on human
reproduction, embryonic and fetal development and postnatal (e.g.,
mental) development.

**** SECTION 4 - FIRST AID MEASURES ****

Eyes:
Immediately flush eyes with plenty of water for at least 15 minutes,
occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at
least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical
aid immediately. Do NOT induce vomiting. If conscious and alert,
rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing
is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth
resuscitation. If breathing has ceased apply artificial respiration
using oxygen and a suitable mechanical device such as a bag and a
mask.
Notes to Physician:
Treat symptomatically and supportively.
Antidote:
The use of d-Penicillamine as a chelating agent should be determined
by qualified medical personnel. The use of Dimercaprol or BAL
(British Anti-Lewisite) as a chelating agent should be determined by
qualified medical personnel. The use of Calcium disodium EDTA as a
chelating agent should be determined by qualified medical personnel.

**** SECTION 5 - FIRE FIGHTING MEASURES ****

General Information:
As in any fire, wear a self-contained breathing apparatus in
pressure-demand, MSHA/NIOSH (approved or equivalent), and full
protective gear. During a fire, irritating and highly toxic gases
may be generated by thermal decomposition or combustion. Containers
may explode when heated. Non-combustible, substance itself does not
burn but may decompose upon heating to produce irritating, corrosive
and/or toxic fumes. Runoff from fire control or dilution water may
cause pollution.
Extinguishing Media:
Use agent most appropriate to extinguish fire. For small fires, use
dry chemical, carbon dioxide, or water spray. For large fires, use
water spray, fog or regular foam.

**** SECTION 6 - ACCIDENTAL RELEASE MEASURES ****

General Information: Use proper personal protective equipment as indicated
in Section 8.
Spills/Leaks:
Clean up spills immediately, observing precautions in the Protective
Equipment section. Sweep up, then place into a suitable container for
disposal. Avoid generating dusty conditions. Provide ventilation.

**** SECTION 7 - HANDLING and STORAGE ****

Handling:
Wash thoroughly after handling. Remove contaminated clothing and
wash before reuse. Use with adequate ventilation. Minimize dust
generation and accumulation. Avoid contact with eyes, skin, and
clothing. Keep container tightly closed. Avoid ingestion and
inhalation.
Storage:
Store in a cool place in the original container and protect from
sunlight. Store in a tightly closed container. Keep from contact with
oxidizing materials.

**** SECTION 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION ****

Engineering Controls:
Facilities storing or utilizing this material should be equipped
with an eyewash facility and a safety shower. Use adequate
ventilation to keep airborne concentrations low.
Exposure Limits
CAS# 10101-63-0:
United Kingdom, WEL - TWA: (listed as lead compounds): 0.15 mg/m3
(as Pb)
United Kingdom, WEL - STEL: (listed as lead compounds): 0.45 mg/m
TWA (as Pb)
United States OSHA: 50 ??g/m3 TWA (as Pb); 30 ??g/m3 Action Level (
Pb. Poison - see 29 CFR 1910.10 25) (listed under Lead, inorgani
compounds).
Belgium - TWA: (listed as lead, inorganic compounds): 0.15 mg/m3
(dust and fume)
France - VME: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Germany: (listed as lead compounds): 0.1 mg/m3 VME (as Pb)
Japan: (listed as lead compounds): 0.1 mg/m3 OEL (except alkyl le
compounds, as Pb)
Malaysia: (listed as lead, inorganic compounds): 0.05 mg/m3 TWA (
Pb)
Netherlands: (listed as lead, inorganic compounds): 0.15 mg/m3 MA
(dust and smoke, as Pb)
Russia: (listed as lead, inorganic compounds): 0.5 mg/m3 TWA (as
Spain: (listed as lead, inorganic compounds): 0.15 mg/m3 VLA-ED (
Pb)

Personal Protective Equipment

Eyes:
Wear appropriate protective eyeglasses or chemical
safety goggles as described by OSHA's eye and face
protection regulations in 29 CFR 1910.133 or European
Standard EN166.
Skin:
Wear appropriate protective gloves and clothing to
prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin
exposure.
Respirators:
Follow the OSHA respirator regulations found in 29
CFR 1910.134 or European Standard EN 149. Use a
NIOSH/MSHA or European Standard EN 149 approved
respirator if exposure limits are exceeded or if
irritation or other symptoms are experienced.

**** SECTION 9 - PHYSICAL AND CHEMICAL PROPERTIES ****

Physical State: Powder
Color: orange
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 402 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: 6.1600g/cm3
Molecular Formula: I2Pb
Molecular Weight: 461.00

**** SECTION 10 - STABILITY AND REACTIVITY ****

Chemical Stability:
Stable at room temperature in closed containers under normal storage
and handling conditions.
Conditions to Avoid:
Incompatible materials, light, dust generation, excess heat, strong
oxidants.
Incompatibilities with Other Materials:
Strong oxidizers.
Hazardous Decomposition Products:
Irritating and toxic fumes and gases, hydrogen iodide, lead/lead
oxides.
Hazardous Polymerization: Has not been reported

**** SECTION 11 - TOXICOLOGICAL INFORMATION ****

RTECS#:
CAS# 10101-63-0 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Lead (II) Iodide -
California: carcinogen, initial date 10/1/92 (listed as Lead compounds
NTP: Suspect carcinogen (listed as Lead compounds).
IARC: Group 2A carcinogen (listed as Lead, inorganic compounds).

**** SECTION 12 - ECOLOGICAL INFORMATION ****



**** SECTION 13 - DISPOSAL CONSIDERATIONS ****

Dispose of in a manner consistent with federal, state, and local regulations.

**** SECTION 14 - TRANSPORT INFORMATION ****

IATA
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
IMO
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing Group: III
RID/ADR
Shipping Name: LEAD COMPOUND, SOLUBLE, N.O.S.
Hazard Class: 6.1
UN Number: 2291
Packing group: III
USA RQ: CAS# 10101-63-0: 10 lb final RQ; 4.54 kg final RQ

**** SECTION 15 - REGULATORY INFORMATION ****

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: T N
Risk Phrases:
R 61 May cause harm to the unborn child.
R 20/22 Harmful by inhalation and if swallowed.
R 33 Danger of cumulative effects.
R 50/53 Very toxic to aquatic organisms, may cause
long-term adverse effects in the aquatic environment.
R 62 Possible risk of impaired fertility.
Safety Phrases:
S 53 Avoid exposure - obtain special instructions
before use.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
S 60 This material and its container must be
disposed of as hazardous waste.
S 61 Avoid release to the environment. Refer to
special instructions/safety data sheets.
WGK (Water Danger/Protection)
CAS# 10101-63-0: No information available.
Canada
CAS# 10101-63-0 is listed on Canada's NDSL List.
CAS# 10101-63-0 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 10101-63-0 is listed on the TSCA inventory.

**** SECTION 16 - ADDITIONAL INFORMATION ****

MSDS Creation Date: 9/02/1997 Revision #4 Date: 3/18/2003

The information above is believed to be accurate and represents the best
information currently available to us. However, we make no warranty of
merchantability or any other warranty, express or implied, with respect to
such information, and we assume no liability resulting from its use. Users
should make their own investigations to determine the suitability of the
information for their particular purposes. In no way shall the company be
liable for any claims, losses, or damages of any third party or for lost
profits or any special, indirect, incidental, consequential or exemplary
damages, howsoever arising, even if the company has been advised of
the possibility of such damages.
--------------------------------------------------------------------------------
--------------------------------------------------------------------------------
Search More   
ALL MSDS PAGES IN THIS GROUP
NAMECAS
Sodium Hydroxide 0.2N Solution 1310-73-2
3-Methylcyclohexanone, 97% 591-24-2
Tert.-butylcyclohexane, 99+% 3178-22-1
4-Methoxyphenol 150-76-5
Sodium bis(trimethylsilyl)amide, 2M solution in THF 109-99-9
D,L-Alanine Anhydride, 99% 5625-46-7
3-Iodobenzotrifluoride 98% 401-81-0
Dicyanine A, 98% (UV-Vis) 20591-23-5
Lead (II) Bromide 10031-22-8
Lanthanum Nitrate 10099-59-9
Lanolin 8006-54-0
Methyl Ammonium Chloride 593-51-1
Lead(II) Iodide, 99% 10101-63-0
Carbon Lamp Black 1333-86-4
Lactose 63-42-3
N-Methylaniline 100-61-8
Lactic Acid 50-21-5
Lacmoid 42249-61-6
Methyldiglycol 111-77-3
Methyl formate 107-31-3
Sodium tetraborate, anhydrous 1330-43-4
N-Methylimidazole 616-47-7
1-Bromoadamantane, 99% 768-90-1
4% Boric Acid Solution with Indicator 7732-18-5
Kjeldahl Catalyst Tablets (Sodium Sulfate) 7757-82-6
Kjeldahl Catalyst Tablets (Selenium) 7757-82-6
Kjeldahl Catalyst Tablets (Mercury) 7439-97-6
Kjeldahl Catalyst Tablets (Copper) 7757-82-6
N-Methyl-N-nitroso-p-toluenesulfonamide (Not currently sold) 80-11-5
Kieselguhr 61790-53-2
0.04% Methyl orange solution 64-17-5
Di-Lauroyl Peroxide 105-74-8
2,3-Pyrazinedicarboxylic Acid, 97%
Mercury (II) oxycyanide 1335-31-5
Xanthydrol Solution 67-56-1
2-Thiophenecarboxylic acid, 99% 527-72-0
Water Solution for Karl Fischer 67-56-1
Methylated Spirit (Mineralized) 64-17-5
0.1M Tetra-n-butyl ammonium hydroxide solution 67-56-1
0.0125M Sulfuric Acid 7664-93-9
Methylated Spirit (industrial) 64 OP 64-17-5
Methylated spirit (industrial) 74 OP 64-17-5
Methyl orange - xylene cyanol FF solution 64-17-5
2-Methylpentan-2,4-Diol 107-41-5
Sodium arsenite, 0.05M (0.1N) Standard Solution for Volumetric 7732-18-5
Silver Sulfate Solution in Sulfuric Acid 7664-93-9
Silver Nitrate Solution 1200 g/L 7732-18-5
Silver Nitrate Solution 1000g/l 7732-18-5
N-Methyl-N-trimethylsilyltrifluoroacetamide 24589-78-4
Silver Nitrate Solution (0.0282M) 7732-18-5

Free MSDS Search ( Providing 250,000+ Material Properties )
Chemcas.com| Ads link:todaystock.net